UK markets closed
NIKKEI 225
39,069.68 +282.30 (+0.73%) HANG SENG
19,636.22 +82.61 (+0.42%) CRUDE OIL
79.71 -0.35 (-0.44%) GOLD FUTURES
2,430.50 +13.10 (+0.54%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
54,872.76 +2,719.03 (+5.21%)
OMER Jan 2025 2.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:28AM EDT. Market open.
| Previous close | 1.5400 |
| Open | 1.5600 |
| Bid | 0.0000 |
| Ask | 2.0000 |
| Strike | 2.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.5400 - 1.5600 |
| Contract range | N/A |
| Volume | |
| Open interest | 112 |
- GuruFocus.com
Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...
Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.
Business WireOmeros Corporation Reports First Quarter 2024 Financial Results
SEATTLE, May 15, 2024--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders, today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024, which include:
© 2024 Yahoo. All rights reserved.